American Journal of Cardiology
Volume 105, Issue 6 , Pages 884-887 , 15 March 2010

Prevalence and Clinical Characteristics of Nondilated Cardiomyopathy and the Effect of Atrial Fibrillation

Received 10 July 2009 ,Revised 30 October 2009 ,Accepted 30 October 2009.

References 

  1. Cohn JN, Ferrari R, Sharpe N. Cardiac remodeling-concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. J Am Coll Cardiol. 2000;35:569–582
  2. Gaasch WH, Delorey DE, St. John Sutton MG, Zile MR. Patterns of structural and functional remodeling of the left ventricle in chronic heart failure. Am J Cardiol. 2008;102:459–462
  3. Keren A, Gottlieb S, Tzivoni D, Stern S, Yarom R, Billingham ME, et al. Mildly dilated congestive cardiomyopathy: use of prospective diagnostic criteria and description of the clinical course without heart transplantation. Circulation. 1990;81:506–517
  4. Gavazzi A, DeMaria R, Renosto G, Moro A, Borgia M, Caroli A, et al. The spectrum of left ventricular size in dilated cardiomyopathy: clinical correlates and prognostic implications. Am Heart J. 1993;125:410–422
  5. Kikaoka H, Matsumura Y, Yamasaki N, Kondo F, Furuno T, Doi Y. Long-term prognosis of patients with mildly dilated cardiomyopathy. Circ J. 2002;66:557–560
  6. Coffi G, Tarantini L, Defeo S, Pulignano G, Del Sindaco D, Stefenelli C, et al. Dilated versus non-dilated cardiomyopathy in the elderly population treated with guideline-based medical therapy for systolic chronic heart failure. J Card Fail. 2004;10:481–489
  7. Mathew RK, Gaasch WH, Guilmette NE, Schick EC, Labib SB. Anthropometric normalization of left ventricular size in chronic mitral regurgitation. Am J Cardiol. 2003;91:762–764
  8. Teicholz LE, Kruelen T, Herman MV, Gorlin R. Problems in echocardiographic volume determinations: echocardiographic-angiographic correlations in the presence or absence of asynergy. Am J Cardiol. 1997;37:7–11
  9. St John Sutton MG, Plappert T, Hilpisch KE, Abraham WT, Hayes DL, Chinchoy E. Sustained reverse left ventricular structural remodeling with cardiac resynchronization at one year is a function of etiology. Circulation. 2006;113:266–272
  10. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, et al. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult—summary article. Circulation. 2005;112:1825–1852
  11. MERIT-HF Study Group. Effect of metoprolol CR/XL in chronic heart failure: metoprolol CR/XL randomized intervention trial in congestive heart failure (MERIT-HF). Lancet. 1999;353:2001–2007
  12. Cohn JN, Tognoni G. A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure. N Engl J Med. 2001;345:1667–1675
  13. Pfeffer MA, Swedberg K, Granger CB, Helf P, McMurray JJV, Michelson EL, et al. Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM—overall program. Lancet. 2003;362:759–766
  14. Ronco C, Haapio M, House AA, Anaverkar N, Bellomo R. Cardiorenal syndrome. J Am Coll Cardiol. 2008;52:1527–1539
  15. Arcement LM, Hebert K, Bakshi , Ventura H. Prevalence of thyroid abnormalities in indigent ambulatory systolic heart failure patients. Chest. 2003;124:185S
  16. The SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med. 1992;327:685–691
  17. Gaasch WH. Diagnosis and treatment of heart failure based on left ventricular systolic or diastolic dysfunction. JAMA. 1994;271:1276–1280
  18. Bristow JD, Vanzee BE, Judkins MP. Systolic and diastolic abnormalities of the left ventricle in coronary artery disease: studies in patients with little or no enlargement of ventricular volume. Circulation. 1970;62:219–228
  19. Rame JE, Ramilo M, Spencer N, Blewett C, Mehta SK, Dries DL, et al. Development of a depressed left ventricular ejection fraction in patients with left ventricular hypertrophy and a normal ejection fraction. Am J Cardiol. 2004;93:234–237
  20. Drazner MH, Rame JE, Marino EK, Gottdiener JS, Kitzman DW, Gardin JM, et al. Increased left ventricular mass is a risk factor for the development of a depressed left ventricular ejection fraction within five years. J Am Coll Cardiol. 2004;43:2207–2215

PII: S0002-9149(09)02763-5

doi: 10.1016/j.amjcard.2009.10.068

American Journal of Cardiology
Volume 105, Issue 6 , Pages 884-887 , 15 March 2010

Article Tools